Anticipated Uptake and Impact of Genetic Testing in Hereditary Breast and Ovarian Cancer Families

Cancer Epidemiology Biomarkers and Prevention

Volumn 4, Issue 2, 1995, Pages 169-173

  Struewing, Jeffery P ^a   Lerman, Caryn ^b   Kase, Ronald G ^c   Giambarresi, Therese R ^c   Tucker, Margaret A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c WESTAT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER SUSCEPTIBILITY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; GENETIC LINKAGE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PATIENT COUNSELING; PRIORITY JOURNAL;

ADULT; AGED; ATTITUDE TO HEALTH; BREAST NEOPLASMS; COMPARATIVE STUDY; FEMALE; FOLLOW-UP STUDIES; GENETIC COUNSELING; GENETIC SCREENING; HETEROZYGOTE; HUMAN; LINKAGE (GENETICS); MALE; MIDDLE AGE; MOTIVATION; MUTATION; OVARIAN NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; RISK FACTORS; SEX FACTORS;

EID: 0028954025     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hall, J. M., Lee, M. K., Newman, B., Morrow, J. E., Anderson, L. A., Huey, B., and King, M. C. Linkage of early-onset familial breast cancer to chromosome 17q21. Science (Washington DC), 250: 1684–1689, 1990.
2. Easton, D. F., Bishop, D. T., Ford, D., Crockford, G. P., and the Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am. J. Hum. Genet. 52: 678–701, 1993.
3. Ford, D., Easton, D. F., Bishop, D. T., Narod, S. A., and the Breast Cancer Linkage Consortium. The risks of cancer in BRCA1 mutation carriers. Abstract. Am. J. Hum. Genet. 53 (Suppl.): 298, 1993.
4. Biesecker, B. B., Boehnke, M., and Calzone, K., Markel, D. S., Garber, J. E., Collins, F. S., and Weber, B. L. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA, 269: 1970–1974, 1993.
5. King, M. C., Rowell, S., and Love, S. M. Inherited breast and ovarian cancer. What are the risks? What are the choices? JAMA, 269: 1975–1980, 1993.
6. Lynch, H. T., Watson, P., Conway, T. A., Lynch, J. F., Slominski-Caster, S. M., Narod, S. A., Feunteun, J. and Lenoir, G. DNA screening for breast/ovarian cancer susceptibility based on linked markers. Arch. Intern. Med., 153: 1979–1987, 1993.
7. Nowak, R. Breast cancer gene offers surprises. Science (Washington DC), 265: 1796–1799, 1994.
8. Lerman, C., and Croyle, R. Psychological issues in genetic screening for breast cancer susceptibility. Arch. Int. Med., 154: 609–616, 1994.
9. Lerman, C., Daly, M., Masny, A., and Balshem, A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J. Clin. Oncol., 12: 843–850, 1993.
10. Craufurd, D., Dodge, A., Kerzin, S. L., and Harris, R. Uptake of presymptomatic predictive testing for Huntington's disease. Lancet, 2: 603–605, 1989.
11. Evers-Kiebooms, G., Swerts, A., Cassiman, J. J., and Van den Berghe, H. The motivation of at-risk individuals and their partners in deciding for or against predictive testing for Huntington's disease. Clin. Genet., 35: 29–40, 1989.
12. Ostrer, H., Allen, W., Crandall, I. A., Moseley, R. E., Dewar, M. E., Nye, D., and McCrary, S. V. Insurance and genetic testing: where are we now? Am. J. Hum. Genet., 52: 565–577, 1993.
13. Wiggins, S., Whyte, P., Huggins, M., Adam, S., Theilmann, J., Bloch, M., Sheps, S. B., Schechter, M. T., and Hayden, M. R. The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N. Engl. J. Med., 327: 1401–1405, 1992.
14. National Advisory Council for Human Genome Research. Statement on use of DNA testing for presymptomatic identification of cancer risk. JAMA, 271: 785, 1994.
15. Lerman, C., and Croyle, R. Genetic testing for cancer predisposition: behavioral science issues. J. Natl. Cancer Inst., in press, 1995.